Editas Medicine, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Editas Medicine, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2014 to 2023.
  • Editas Medicine, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$62.1M, a 38% decline year-over-year.
  • Editas Medicine, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$211M, a 7.94% decline year-over-year.
  • Editas Medicine, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$153M, a 30.5% increase from 2022.
  • Editas Medicine, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$220M, a 14.5% decline from 2021.
  • Editas Medicine, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$193M, a 66% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$153M +$67.2M +30.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 -$220M -$27.9M -14.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 -$193M -$76.5M -66% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 -$116M +$17.8M +13.3% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-22
2019 -$134M -$23.8M -21.6% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 -$110M +$10.4M +8.62% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 -$120M -$23.1M -23.8% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-26
2016 -$97.2M -$24.3M -33.3% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
2015 -$72.9M -$59.2M -433% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-08
2014 -$13.7M Jan 1, 2014 Dec 31, 2014 10-K 2017-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.